Ocular Therapeutix (OCUL) Raw Materials (2014 - 2026)
Ocular Therapeutix's (OCUL) quarterly Raw Materials came in at $287000.0 in Q1 2026, up 53.48% year-on-year from $187000.0 in Q1 2025, and up 42.08% quarter-over-quarter from $202000.0 in Q4 2025.
Ocular Therapeutix (OCUL) Raw Materials (2014 - 2026) Analysis & Trends
Ocular Therapeutix's Raw Materials history runs 13 years deep, the most recent figure standing at $287000.0 for Q1 2026.
- On a quarterly basis, Raw Materials rose 53.48% year-over-year to $287000.0 in Q1 2026; TTM through Mar 2026 was $287000.0, a 53.48% increase from a year earlier, with the FY2025 full-year figure at $202000.0, down 5.61% from the prior year.
- Raw Materials improved to $287000.0 in Q1 2026 per OCUL's latest filing, from $202000.0 in the prior quarter.
- Across five years, Raw Materials topped out at $341000.0 in Q2 2023 and bottomed at $187000.0 in Q1 2025.
- The 5-year median for Raw Materials is $287000.0 (2026), against an average of $269235.3.
- Across the five-year window, Raw Materials plunged 43.16% in 2025 and soared 53.48% in 2026, its largest moves.
- Year by year, Raw Materials stood at $309000.0 in 2022, then fell by 2.27% to $302000.0 in 2023, then retreated by 29.14% to $214000.0 in 2024, then decreased by 5.61% to $202000.0 in 2025, then soared by 42.08% to $287000.0 in 2026.
- Per Business Quant, the three latest OCUL Raw Materials figures stand at $287000.0 (Q1 2026), $202000.0 (Q4 2025), and $229000.0 (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Ocular Therapeutix | 1.93 Bn | 1.93 Bn | 9.46 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 287,000.00 |
| Dec 31, 2025 | 202,000.00 |
| Sep 30, 2025 | 229,000.00 |
| Jun 30, 2025 | 219,000.00 |
| Mar 31, 2025 | 187,000.00 |
| Dec 31, 2024 | 214,000.00 |
| Sep 30, 2024 | 196,000.00 |
| Jun 30, 2024 | 267,000.00 |
| Mar 31, 2024 | 329,000.00 |
| Dec 31, 2023 | 302,000.00 |
| Sep 30, 2023 | 293,000.00 |
| Jun 30, 2023 | 341,000.00 |
| Mar 31, 2023 | 228,000.00 |
| Dec 31, 2022 | 309,000.00 |
| Sep 30, 2022 | 317,000.00 |
| Jun 30, 2022 | 325,000.00 |
| Mar 31, 2022 | 332,000.00 |
| Dec 31, 2021 | 388,000.00 |
| Sep 30, 2021 | 370,000.00 |
| Jun 30, 2021 | 347,000.00 |